GLO Pharma, Inc.
Funding rounds
2 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Aug 2021 | $53 M | No. 2 | $50 to $250 million | equity | SEC | |
| Nov 2020 | $7 M | No. 1 | $2 to $10 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
GLO Pharma, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2023).
SEC Form D · Sep 2023
The industry group it chose in its notices: Pharmaceuticals.
SEC Form D · Sep 2023
That is all the official record says: GLO Pharma, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of GLO Pharma, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 189 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Lauren Otsuki | Executive officer | Sep 2023 |
| Vimla Black-Gupta | Executive officer | Sep 2023 |
| Scott Glenn | Executive officer | Jun 2022 |
| Dayna Quanbeck | Director | Sep 2023 |
| Douglas Wall | Director | Sep 2023 |
| Fabian Seelbach | Director | Sep 2023 |
| Lauren Otsuki | Director | Sep 2023 |
| Marla Beck | Director | Sep 2023 |
| Maureen Case | Director | Sep 2023 |
| Nicole Quinn | Director | Sep 2023 |
| Vimla Black-Gupta | Director | Sep 2023 |
| Brent Saunders | Director | Apr 2023 |
| Scott Glenn | Director | Apr 2023 |
| Carol Shen | Director | Jun 2022 |
| Todd Jackson | Director | Feb 2022 |
| Jana Messersmith | Director | Nov 2020 |